DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Zhu AX, Baron AD, Malfertheiner P. et al.
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: analysis of REACH trial results by Child-Pugh Score.
JAMA Oncol 2016; Sept 22.
DOI: 10.1001/jamaoncol.2016.4115. [Epub ahead of print]
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.